MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Treatment"

  • 2024 International Congress

    Essential3: An Innovative Multi-Study Phase 3 Program to Evaluate the Efficacy and Safety of Ulixacaltamide

    R. Able, M. Giroux, J. Zhao, H. Jacotin, M. Sniecinski, A. Samaroo, A. La Croix, A. Wyant, C. Santos, M. Souza (Boston, USA)

    Objective: An innovative, multi-study Phase 3 program to definitively assess safety and efficacy of ulixacaltamide in essential tremor (ET). Background: Phase 2 studies of ulixacaltamide,…
  • 2024 International Congress

    Magnetic resonance-guided focused ultrasounds (MRgFUS) thalamotomy for disabling tremor secondary to multiple sclerosis.

    A. Menéndez, L. Ispierto, M. Tardaguila, J. Muñoz, C. Ramo-Tello, A. González, R. Alvarez, D. Vilas (Badalona, Spain)

    Objective: To describe two patients with disabling tremor secondary to multiple sclerosis (MS) treated with magnetic resonance-guided focused ultrasounds (MRgFUS) thalamotomy. Background: MRgFUS thalamotomy improves…
  • 2024 International Congress

    Istradefylline effects on L-Dopa resistant tremor in Parkinson’s disease

    G. Ozay, I. Zhang, M. Umali, L. Lovelace, M. Barry, L. Ariza Serrano, A. Sharma, L. Raslan, Y. Torres-Yaghi, F. Pagan (Washington, USA)

    Objective: Quantifying Istradefylline(IST) effects in L-Dopa(LD) resistant tremor in Parkinson’s disease(PD) patients. Background: The adenosine A2A receptors control the indirect pathway. Adenosine A2A receptor activation decreases…
  • 2024 International Congress

    Assessing the Economic Impact of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Real-World Evidence Study Protocol

    D. Dai, J. Fernandes, L. Samuel, C. Lu, S. Reitmaier, A. Berk (Woonsocket, USA)

    Objective: To assess differences in healthcare resource utilization (HCRU) and costs between patients with essential tremor (ET) receiving transcutaneous afferent patterned stimulation (TAPS) therapy and…
  • 2024 International Congress

    MR-guided focused ultrasound for essential tremor: exploratory analysis comparing unilateral and staged, bilateral thalamotomy

    HM. Eisenberg, P. Fishman, P. Ghanouni, M. Grassman, C. Ferrer, K. Gant, A. Grinspan (Baltimore, USA)

    Objective: This exploratory analysis investigated tremor-motor (TM) outcomes in patients receiving unilateral versus staged, bilateral magnetic resonance-guided focused ultrasound (MRgFUS) VIM thalamotomy for essential tremor…
  • 2024 International Congress

    Clinical effectiveness and safety of staged-bilateral MRgFUS for treating essential tremor, a literature review

    E. Natera Villalba, S. Paschen, M. Del Alamo, R. Martinez Fernandez, AK. Helmers (Madrid, Spain)

    Objective: To perform a literature overview of the clinical effectiveness and safety of staged-bilateral MR-guided focused ultrasound (MRgFUS)  in essential tremor. Background: In the brain,…
  • 2024 International Congress

    Patient Experience during Automated Deep Brain Stimulation (DBS) Changing for Sleep (PEACe study)

    S. Fay, K. Au, K. Lyons, Y. Pathak, R. Pahwa (Kansas City, USA)

    Objective: To evaluate the feasibility of an automated intermittent deep brain stimulation (DBS) sleep program in essential tremor (ET) patients with ventralis intermedius nucleus (VIM)…
  • 2024 International Congress

    Clinical Trends and Clinician Perceptions Regarding Asleep and Awake DBS

    Y. Gordeyeva, B. Dalm, L. Almeida, S. de Jesus, A. Fasano, K. Foote, J. Jimenez-Shahed, D. Pathadan, N. Pouratian, J. Rolston, J. Rosenow, D. Safarpour, J. Schwalb, M. Siddiqui, M. Spindler, A. Tsai, J. Wong, L. Metman (Poznan, Poland)

    Objective: To determine trends and perceptions regarding Asleep and Awake Deep Brain Stimulation (DBS) in the USA and abroad. Background: DBS clinical practice continues to…
  • 2024 International Congress

    Perceptions Regarding Asleep and Awake DBS Among Neurologists and Neurosurgeons

    A. Tsai, B. Dalm, L. Almeida, S. de Jesus, A. Fasano, K. Foote, Y. Gordeyeva, J. Jimenez-Shahed, D. Pathadan, N. Pouratian, J. Rolston, J. Rosenow, D. Safarpour, J. Schwalb, M. Siddiqui, M. Spindler, J. Wong, L. Verhagen Metman (Columbus, USA)

    Objective: To compare trends and perceptions regarding Asleep and Awake deep brain stimulation (DBS) between neurologists (NLGs) and neurosurgeons (NSXs) in the USA and abroad.…
  • 2024 International Congress

    Clinical Trends in Asleep and Awake DBS in North America vs Europe

    D. Pathadan, B. Dalm, L. Almeida, S. de Jesus, A. Fasano, K. Foote, Y. Gordeyeva, J. Jimenez-Shahed, N. Pouratian, J. Rolston, J. Rosenow, D. Safarpour, J. Schwalb, M. Siddiqui, M. Spindler, A. Tsai, J. Wong, L. Metmen (Bengaluru, India)

    Objective: To compare trends and perceptions regarding Asleep and Awake deep brain stimulation (DBS) in North America (NA) and Europe (EU). Background: DBS clinical practice…
  • 1
  • 2
  • 3
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley